Literature DB >> 15129325

Enzyme inhibitors of marine microbial origin with pharmaceutical importance.

Chiaki Imada1.   

Abstract

Several enzyme inhibitors with various industrial uses were isolated from bacteria and actinomycetes living in the marine environment. These inhibitors are useful in medicine and agriculture. All the compounds, except the monoamine oxidase inhibitors, are novel, and their activities have been characterized.

Mesh：

Substances：

Year:  2004        PMID： 15129325     DOI： 10.1007/s10126-003-0027-3

Source DB:  PubMed          Journal:  Mar Biotechnol (NY)        ISSN： 1436-2228            Impact factor:   3.619


  25 in total

1.  Design, synthesis and biological activity of novel non-peptidyl endothelin converting enzyme inhibitors, 1-phenyl-tetrazole-formazan analogues.

Authors:  Kazuto Yamazaki; Hirohiko Hasegawa; Kayo Umekawa; Yasuyuki Ueki; Naohito Ohashi; Masaharu Kanaoka
Journal:  Bioorg Med Chem Lett       Date:  2002-05-06       Impact factor: 2.823

2.  Pyrizinostatin: a new inhibitor of pyroglutamyl peptidase.

Authors:  T Aoyagi; M Hatsu; C Imada; H Naganawa; Y Okami; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1992-11       Impact factor: 2.649

3.  Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus.

Authors:  Akihiko Ogata; Naoya Hamaue; Mutsuko Terado; Masaru Minami; Kazuo Nagashima; Kunio Tashiro
Journal:  J Neurol Sci       Date:  2003-01-15       Impact factor: 3.181

4.  Symbiotic marine bacteria chemically defend crustacean embryos from a pathogenic fungus.

Authors:  M S Gil-Turnes; M E Hay; W Fenical
Journal:  Science       Date:  1989-10-06       Impact factor: 47.728

5.  Influence of an -amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man.

Authors:  W Puls; U Keup
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

6.  WS79089A, B and C, new endothelin converting enzyme inhibitors isolated from Streptosporangium roseum. No. 79089. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  Y Tsurumi; N Ohhata; T Iwamoto; N Shigematsu; K Sakamoto; M Nishikawa; S Kiyoto; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1994-06       Impact factor: 2.649

7.  Plasminostreptin, a protein proteinase inhibitor produced by Streptomyces antifibrinolyticus. III. Elucidation of the primary structure.

Authors:  H Sugino; A Kakinuma; S Iwanaga
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

Review 8.  Chitin metabolism: a target for drugs against parasites.

Authors:  K D Spindler; M Spindler-Barth; M Londershausen
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

9.  Pyrostatins A and B, new inhibitors of N-acetyl-beta-D-glucosaminidase, produced by Streptomyces sp. SA-3501.

Authors:  T Aoyama; F Kojima; C Imada; Y Muraoka; H Naganawa; Y Okami; T Takeuchi; T Aoyagi
Journal:  J Enzyme Inhib       Date:  1995

10.  Variant serum beta-hexosaminidase as a biochemical marker of malignancy.

Authors:  M C Plucinsky; J J Prorok; J A Alhadeff
Journal:  Cancer       Date:  1986-10-01       Impact factor: 6.860
View more
  8 in total

1.  Research on marine actinobacteria in India.

Authors:  K Sivakumar; Maloy Kumar Sahu; T Thangaradjou; L Kannan
Journal:  Indian J Microbiol       Date:  2007-10-04       Impact factor: 2.461

2.  Potential Anticoagulant Activity of Trypsin Inhibitor Purified from an Isolated Marine Bacterium Oceanimonas Sp. BPMS22 and its Kinetics.

Authors:  B S Harish; Kiran Babu Uppuluri
Journal:  Mar Biotechnol (NY)       Date:  2018-08-18       Impact factor: 3.619

Review 3.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

4.  Diversity and antagonistic potential of marine microbes collected from south-west coast of India.

Authors:  S Sinimol; A R Sarika; A Jayakumaran Nair
Journal:  3 Biotech       Date:  2015-12-31       Impact factor: 2.406

Review 5.  Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.

Authors:  Nadia Ruocco; Susan Costantini; Flora Palumbo; Maria Costantini
Journal:  Mar Drugs       Date:  2017-06-12       Impact factor: 5.118

6.  Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Haliclona sp.

Authors:  Pierre-Eric Campos; Gaëtan Herbette; Christophe Chendo; Patricia Clerc; Florent Tintillier; Nicole J de Voogd; Eleni-Dimitra Papanagnou; Ioannis P Trougakos; Moran Jerabek; Jérôme Bignon; Géraldine Le Goff; Jamal Ouazzani; Anne Gauvin-Bialecki
Journal:  Mar Drugs       Date:  2020-07-03       Impact factor: 5.118

7.  Efficacy of Alpha Glucosidase Inhibitor from Marine Actinobacterium in the Control of Postprandial Hyperglycaemia in Streptozotocin (STZ) Induced Diabetic Male Albino Wister Rats.

Authors:  S R Sathish Kumar; K V Bhaskara Rao
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 8.  Microbial drug discovery: 80 years of progress.

Authors:  Arnold L Demain; Sergio Sanchez
Journal:  J Antibiot (Tokyo)       Date:  2009-01-09       Impact factor: 2.649
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.